Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
Public ClinicalTrials.gov record NCT00038662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study Evaluating the Safety and Efficacy of Atrasentan (ABT-627) in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
Study identification
- NCT ID
- NCT00038662
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Abbott
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Atrasentan Drug
Drug
Eligibility (public fields only)
- Age range
- 19 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2002
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Aug 14, 2006
Started 2002
United States locations
- U.S. sites
- 24
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urology Centers Of Alabama | Homewood | Alabama | 35205 | — |
| Alaska Clinical Research Center, LLC | Anchorage | Alaska | 99508 | — |
| Arkansas Urologial Associates, PA | Little Rock | Arkansas | 72205 | — |
| San Diego Urology Center | La Mesa | California | 91942 | — |
| Western Clinical Research Inc | Torrance | California | 90505 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Clinical Physiology Associates | Fort Myers | Florida | 33916 | — |
| Southeastern Urological Center, PA | Tallahassee | Florida | 32308 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Johns Hopkins Oncology Center | Baltimore | Maryland | 21231-1000 | — |
| Sheldon Freedman MD | Las Vegas | Nevada | 89109 | — |
| VA Medical Center(111) | Reno | Nevada | 89502 | — |
| Nevada Urology Associates | Reno | Nevada | 89511 | — |
| Carolinas Medical Centre | Charlotte | North Carolina | 28204 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Urologic Specialists Of Oklahoma, Inc. | Tulsa | Oklahoma | 74104-5433 | — |
| Oregon Urology Specialists | Eugene | Oregon | 97401 | — |
| Urological Assoc. of Lancaster | Lancaster | Pennsylvania | 17604-3200 | — |
| University Of Pittsburgh | Pittsburgh | Pennsylvania | 15232 | — |
| Center for Urologic Care | West Reading | Pennsylvania | 19611 | — |
| Ntouch Research Corporation | Dallas | Texas | 75230 | — |
| Salt Lake Research | Salt Lake City | Utah | 84124 | — |
| Jeffrey Frankel, M.D. | Seattle | Washington | 98166-3059 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00038662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2006 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00038662 live on ClinicalTrials.gov.